Robert C. Robbins, MD, president of the University of Arizona, and Kayse Shrum, DO, president of Oklahoma State University, announced the two institutions’ academic medical centers have joined forces to combat the opioid crisis and chronic pain through research, treatment and education.

With highly contagious new COVID-19 variants emerging and driving surges around the world at different times, will we reach a regular "COVID season" anytime soon?

A novel catheter-based cardioneural ablation procedure reduced symptoms of vasovagal syncope, a condition that leads to fainting, by as much as 80% for patients with symptoms despite medical intervention and behavioral modification who did not desire permanent pacing.

The partnership will advance pain and addiction research and accelerate positive health outcomes in Arizona, Oklahoma and across the country.

The article discusses the importance of the recently announced Valley Fever Collaborative, a University of Arizona Health Sciences-led partnership with Arizona State University and Northern Arizona University.

Three new student programs aim to train the next generation of health care professionals and increase access to care across Arizona’s diverse communities.

Novel findings from the Center for Innovation in Brain Science indicate the APOEe4 genotype drives metabolic changes, regardless of patient sex.

A University of Arizona Health Sciences study found that a specific genotype of the APOE gene is able to significantly influence metabolic changes and override sex-specific differences between men and women with Alzheimer’s disease.

Sairam Parthasarathy, MD, a critical care specialist and professor at the College of Medicine – Tucson, is leading the Community Engagement Alliance (CEAL) Against COVID-19 Disparities.